Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb S SayaniDesignation :- Company Secretary and Compliance Officer Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company
Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company Vanta Bioscience Ltd - 540729 - Closure of Trading Window
As per the provisions of the code of conduct and policies for prevention of Insider Trading of the Company, the trading window for transactions in shares of the Company for all designated persons and their immediate relatives will be closed from April 01, 2022 till the 48 hours after the declaration of audited financial results of the Company for the half year and year ended March 31, 2022. The date of Board Meeting for consideration of audited financial results of the Company for the half year and year ended March 31, 2022 shall be intimated in due course of time Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company
Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company
Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company
Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb SayaniDesignation :- Company Secretary and Compliance Officer Vanta Bioscience Ltd - 540729 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order
Receipt of order for testing/studies from Coromandel International Limited Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company
Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company Vanta Bioscience Ltd - 540729 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Vanta Bioscience Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here